Genome sequencing not ready for familial dilated cardiomyopathy

Genome sequencing is not yet ready to be a first line genetic test in familial dilated cardiomyopathy because it yields little extra information, Australian research shows. While genome sequencing is as accurate as current multi-gene panel sequencing for detecting DCM genes, its $6000+ price tag may not be justified for the few additional pathogenic gene ...

Already a member?

Login to keep reading.

© 2021 the limbic